To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan
Clinical trial NCT02162771 · COMPLETED
Trial details
- NCT number
- NCT02162771
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-14
- Primary completion
- 2016-01-12
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.